Podocalyxin-like 1 Monoclonal Antibody

This gene encodes a member of the sialomucin protein family. The encoded protein was originally identified as an important component of glomerular podocytes. Podocytes are highly differentiated epithelial cells with interdigitating foot processes covering the outer aspect of the glomerular basement membrane. Other biological activities of the encoded protein include: binding in a membrane protein complex with Na+/H+ exchanger regulatory factor to intracellular cytoskeletal elements, playing a role in hematopoetic cell differentiation, and being expressed in vascular endothelium cells and binding to L-selectin.

Introducing the PODOCALYXIN-LIKE 1 Monoclonal Antibody, a cutting-edge scientific innovation designed to revolutionize the field of medical research and diagnostics. This meticulously crafted antibody is meticulously engineered to target and bind specifically to the PODOCALYXIN-LIKE 1 protein, offering unparalleled accuracy and precision in its applications.

With its exceptional specificity, the PODOCALYXIN-LIKE 1 Monoclonal Antibody enables researchers and clinicians to delve deeper into the intricate mechanisms of various diseases and disorders. By facilitating the identification and characterization of PODOCALYXIN-LIKE 1 protein expression, this antibody serves as an invaluable tool in elucidating the underlying molecular pathways and potential therapeutic targets.

Crafted with utmost care and adherence to rigorous quality standards, this monoclonal antibody guarantees reproducibility and reliability in experimental settings. Its exceptional affinity and selectivity ensure minimal cross-reactivity, allowing for precise and accurate detection of PODOCALYXIN-LIKE 1 protein in various biological samples.

The PODOCALYXIN-LIKE 1 Monoclonal Antibody is compatible with a wide range of applications, including immunohistochemistry, immunofluorescence, western blotting, and flow cytometry. Its versatility empowers researchers to explore diverse research avenues and unravel the intricate complexities of PODOCALYXIN-LIKE 1 protein expression in different cellular contexts.

Furthermore, this antibody is meticulously formulated to exhibit exceptional stability and longevity, ensuring consistent performance throughout its shelf life. Its user-friendly nature and straightforward protocols make it accessible to both seasoned researchers and newcomers in the field, facilitating seamless integration into existing laboratory workflows.

In summary, the PODOCALYXIN-LIKE 1 Monoclonal Antibody represents a groundbreaking advancement in the realm of medical research and diagnostics. Its unrivaled specificity, reliability, and versatility make it an indispensable asset for scientists and clinicians alike, propelling the boundaries of knowledge and paving the way for novel therapeutic interventions.